Richard E. Chaisson
Impact in
- Virology top 0.05%
- HIV Research and Treatment
- Infectious Diseases top 0.01%
- Tuberculosis Research and Epidemiology
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
-
- Tuberculosis Research and Epidemiology 229
- HIV/AIDS Research and Interventions 63
- HIV/AIDS drug development and treatment 60
- Epidemiology 170
- Pneumocystis jirovecii pneumonia detection and treatment 92
- Mycobacterium research and diagnosis 48
- Co-authors
- Richard D. Moore (56 shared papers)Jeanne C. Keruly (21 shared papers)Gregory M. Lucas (7 shared papers)Joel E. Gallant (16 shared papers)Kelly E. Dooley (18 shared papers)Neil Alexander Martinson (58 shared papers)Jean Bisimwa Nachega (18 shared papers)Thomas C. Quinn (8 shared papers)
- Journals
- AIDS (43 papers)Clinical Infectious Diseases (38 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (30 papers)The International Journal of Tuberculosis and Lung Disease (26 papers)The Journal of Infectious Diseases (20 papers)
- Partner nations
- United StatesSouth AfricaUnited Kingdom
In The Last Decade
Richard E. Chaisson
448 papers receiving 34.1k citations
Richard E. Chaisson's Hit Papers
Peers
Comparison fields: 5 of 187
- Virology 7.2k
- Infectious Diseases 23.4k
- Epidemiology 13.5k
- Emergency Medicine 1.8k
- Hepatology 918
Countries citing papers authored by Richard E. Chaisson
This map shows the geographic impact of Richard E. Chaisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Chaisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Chaisson more than expected).
Fields of papers citing papers by Richard E. Chaisson
This network shows the impact of papers produced by Richard E. Chaisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Chaisson. The network helps show where Richard E. Chaisson may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard E. Chaisson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 459 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy Hit paper breakdown → | 1997 | 2637 |
| 2 | Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy Hit paper breakdown → | 1999 | 1800 |
| 3 | Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Hit paper breakdown → | 2016 | 1060 |
| 4 | Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions Hit paper breakdown → | 1999 | 757 |
| 5 | Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection Hit paper breakdown → | 2011 | 752 |
| 6 | Tuberculosis and diabetes mellitus: convergence of two epidemics Hit paper breakdown → | 2009 | 734 |
| 7 | Latent Mycobacterium tuberculosis Infection Hit paper breakdown → | 2015 | 597 |
| 8 | Cocaine Use and HIV Infection in Intravenous Drug Users in San Francisco Hit paper breakdown → | 1989 | 553 |
| 9 | Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Hit paper breakdown → | 2015 | 479 |
| 10 | 1988 | 477 | |
| 11 | 1992 | 471 | |
| 12 | 2002 | 447 | |
| 13 | 1991 | 402 | |
| 14 | 1987 | 393 | |
| 15 | 1999 | 385 | |
| 16 | 2009 | 368 | |
| 17 | Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis Hit paper breakdown → | 2021 | 366 |
| 18 | 2002 | 348 | |
| 19 | 1993 | 338 | |
| 20 | 2007 | 315 |
About Richard E. Chaisson
Richard E. Chaisson is a scholar working on Infectious Diseases, Epidemiology, Virology, Surgery and Emergency Medicine, having authored 459 papers that have together received 36.1k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (229 papers), Pneumocystis jirovecii pneumonia detection and treatment (92 papers), HIV/AIDS Research and Interventions (63 papers), HIV/AIDS drug development and treatment (60 papers), Mycobacterium research and diagnosis (48 papers), HIV Research and Treatment (47 papers), Infectious Diseases and Tuberculosis (35 papers) and Diagnosis and treatment of tuberculosis (26 papers). The work is most often cited by research in Virology (7.2k citations), Infectious Diseases (23.4k citations), Epidemiology (13.5k citations), Emergency Medicine (1.8k citations) and Hepatology (918 citations). Richard E. Chaisson has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Richard D. Moore, Jeanne C. Keruly, Gregory M. Lucas, Joel E. Gallant, Kelly E. Dooley, Neil Alexander Martinson, Jean Bisimwa Nachega, Thomas C. Quinn, Timothy R. Sterling and Theodore C. Pierson. Their work appears in journals such as AIDS, Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, The International Journal of Tuberculosis and Lung Disease and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.